Research paperDrug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery
References (181)
- et al.
Quantitative approaches to delineate paracellular diffusion in cultures epithelial cell monolayers
J. Pharm. Sci.
(1994) - et al.
Analysis of models for determining intestinal wall permeabilities
J. Pharm. Sci.
(1980) Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells
J. Pharm. Sci.
(1990)- et al.
An in vivo investigation into the suitability of pH dependent polymers for colonic targeting
Int. J. Pharm.
(1993) - et al.
Studies on pectin formulations for colonic drug delivery
J. Controlled Release
(1994) - et al.
Reevaluation of the absorption of carbenoxolone using an in situ rat intestinal technique
J. Pharm. Sci.
(1990) - et al.
Measurements of intestinal permeability using low molecular weight polyethylenglycols (PEG 400)
Gastroenterology
(1977) - et al.
Gastrointestinal sites of furosemide absorption in rats
Int. J. Pharm.
(1979) - et al.
Gastrointestinal transit of pellets of different size and density
Int. J. Pharm.
(1993) - et al.
Comparative gastrointestinal transit of pellet systems of varying density
Int. J. Pharm.
(1995)
The design and evaluation of controlled release systems for the gastrointestinal tract
J. Controlled Release
(1985)
Drug absorption I: an in situ rat gut technique yelding realistic absorption rates
J. Pharm. Sci.
(1969)
Drug absorption III: effect of membrane storage on the kinetics of drug absorption
J. Pharm. Sci.
(1970)
Gastrointestinal parameters that influence oral medications
J. Pharm. Sci.
(1993)
Biodegradable microspheres as a vaccine delivery system
Mol. Immunol.
(1991)
Further investigations into the absorption of dextrometorphan from the rat's stomach
J. Pharm. Sci.
(1969)
Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852
J. Pharm. Sci.
(1989)
Characterization of the intestinal transport parameters for small peptide drugs
J. Controlled Release
(1990)
Colonoscopy in the investigation of drug absorption in healthy volunteers
Gastrointestinal Endoscopy
(1985)
Dosage forms with controlled gastrointestinal passage -studies on the absorption of nitrofuratoin
Int. J. Pharm.
(1989)
GI transit of potential bioadhesive formulations in man: a scintigraphic study
J. Controlled Release
(1990)
GI transit potential bioadhesive systems in the rat
J. Controlled Release
(1990)
In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate
Int. J. Pharm.
(1992)
Biophysical model approaches to mechanistic transepithelial studies of peptides
J. Controlled Release
(1990)
A new multiple-unit oral floating dosage system. II: in vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs
J. Pharm. Sci.
(1991)
Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit
Int. J. Pharm.
(1987)
Absorption of ACE inhibitors from small intestine and colon
J. Pharm. Sci.
(1994)
Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes
Int. J. Pharm.
(1980)
Colonic transit scintigraphy
Gastroenterology
(1986)
Other methods in studying colonic drug absorption
Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments
Pharm. Res.
(1993)
Targeting drugs to the colon: delivery systems for oral administration
J. Drug Targeting
(1994)
Pharmacokinetics of acrivastine after oral and colonic administration
J. Clin. Pharmacol.
(1989)
Gut reaction to tablets and capsules. 2. Physiological factors and controlled-release dosage forms
Pharm. J.
(1982)
Paracellular transport and other mechanisms involved in intestinal peptide absorption
The comparative bioavailability of captopril after colonic infusion and oral administration in healthy volunteers
Clin. Pharmacol. Ther.
(1991)
Absorption of glibenclamide from different sites of the gastro-intestinal tract
Eur. J. Clin. Pharmacol.
(1985)
In vitro/in vivo correlation of dissolution using moments of dissolution and transit times
Acta Pharm. Technol.
(1986)
Kinetics of piretanide absorption from the gastrointestinal tract
Meth. Find. Exp. Clin. Pharmacol.
(1986)
The absorption of piretanide from the gastro-intestinal tract is site-dependent
Eur. J. Clin. Pharmacol.
(1986)
Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation
Pharm. Res.
(1992)
Controlled gastric emptying. I. Effects of physical properties on gastric residence times of nondisintegrating geometric shapes in beagle dogs
Pharm. Res.
(1988)
The forgotten dosage form: enteric-coated tablets
Pharm. Technol.
(1983)
Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers
Pharm. Res.
(1994)
Effect of ‘unstirred’ water layer in the intestine on the rate and extent of absorption after oral absorption
Biopharm. Drug. Dispos.
(1994)
Absorption and disposition of new antiarrhythmic agent bidisomide in man
Pharm. Res.
(1993)
Facteurs physico-chimiques susceptibles d'influencer l'absorption gastro-intestinale après dissolution des principes actifs
Pharm. Acta Helv.
(1976)
Absolute bioavailability of an aqueous solution of l-deamino-8-Darginine vasopressin from different regions of the gastrointestinal tract in man
Eur. J. Clin. Pharmacol.
(1993)
Transit of pharmaceutical dosage forms through the small intestine
Gut
(1986)
Cited by (302)
Administration strategies and smart devices for drug release in specific sites of the upper GI tract
2022, Journal of Controlled ReleaseExpandable, dual-excipient fibrous dosage forms for prolonged delivery of sparingly-soluble drugs
2022, International Journal of PharmaceuticsMechanical strength and gastric residence time of expandable fibrous dosage forms
2022, International Journal of PharmaceuticsCitation Excerpt :Such dosage forms enable the release of drug into the stomach for prolonged time, and hence better control of drug absorption time and drug concentration in blood. This in turn enables improved efficacy, safety, and convenience of many prevailing drug therapies (Davis et al., 1986b; Davis et al., 1988; Rouge et al., 1996; Davis, 2005; Streubel et al., 2006). The concepts mostly examined for gastric retention are the mucoadhesive, floating, and expandable dosage forms.
The effect of weight reduction surgery on the efficacy and tolerability of epilepsy pharmacotherapy
2021, Epilepsy and Behavior
Copyright © 1996 Published by Elsevier B.V.